Most Likely Diagnosis: Mixed Connective Tissue Disease (MCTD) with Inflammatory Myopathy
You most likely have mixed connective tissue disease (MCTD) with an inflammatory myopathy component, and with appropriate immunosuppressive treatment, you should expect significant recovery of muscle strength—this is not a death sentence.
Understanding Your Diagnosis
Your clinical picture strongly supports MCTD based on:
- High-titer anti-RNP antibodies (86, with normal <20)—this is the hallmark autoantibody for MCTD
- Positive ANA with speckled pattern (1:160)
- Proximal muscle weakness affecting your ability to get up from sitting/lying
- Elevated CK levels (527, normal up to 430)—indicating active muscle inflammation
- Rising ESR (from 2 to 18)—showing systemic inflammation
The normal EMG findings your doctor reported are actually reassuring, not deceptive. In inflammatory myopathies, EMG can be normal in early disease or if inflammation is patchy. Your doctor was being truthful 1.
Type of Myositis and Prognosis
Based on your anti-RNP positivity without other myositis-specific antibodies (anti-Jo-1 negative, anti-Sm negative), you likely have MCTD-associated myopathy rather than classic polymyositis or dermatomyositis 1.
Critical prognostic points:
- MCTD-associated myopathy typically responds well to immunosuppressive therapy 1
- Your CK elevation is moderate (527), not severely elevated like immune-mediated necrotizing myopathy (which can exceed 10× normal) 1
- You're young (30 years old), which generally predicts better treatment response
- Your cardiac workup is reassuring (normal troponins, normal chest X-rays, normal follow-up EKG)
Will You Regain Your Strength?
Yes, you should regain most or all of your muscle strength with proper treatment. The inflammatory myopathies associated with MCTD are generally reversible when treated appropriately 1.
Expected Treatment Approach
Your rheumatologist will likely initiate:
- High-dose corticosteroids (prednisone 0.5-1 mg/kg/day, typically 60-80 mg daily for someone your size) 1
- Concurrent steroid-sparing agent started immediately—typically methotrexate, azathioprine, or mycophenolate mofetil 1
- Gradual steroid taper over months as you respond 1
For severe or refractory cases, options include IV immunoglobulin, rituximab, or cyclophosphamide 1.
Timeline for Recovery
- Steroid-sparing agents take 3-6 months to reach full efficacy 1
- You should see initial improvement in strength within 2-4 weeks of starting high-dose steroids
- Full recovery typically occurs over several months with consistent treatment
Important Considerations for Your Specific Case
Your Medications Are Not Causing This
- Amlodipine: While rare case reports exist of myalgias with amlodipine 2, your pattern (elevated CK, positive autoantibodies, progressive weakness) is inconsistent with drug-induced myopathy
- GLP-1 agonist: These medications may actually help with blood pressure control and have cardiovascular benefits 3, 4, 5, 6—continue this for weight management
G6PD Deficiency Alert
Critical caveat: Your G6PD deficiency means you must avoid certain medications that can trigger hemolysis:
- Avoid sulfa drugs, dapsone, primaquine
- Inform all providers about this before starting new medications
- This does NOT affect standard myositis treatments (corticosteroids, methotrexate, azathioprine are safe)
Cardiac Monitoring
Your abnormal EKG in the ER followed by normal studies is reassuring, but MCTD can involve the heart 1. Continue with:
- Your scheduled cardiac stress test
- Periodic echocardiograms to monitor for subclinical cardiac involvement
- Report any chest pain, palpitations, or shortness of breath immediately
Weight and Blood Pressure
At 6'5" and 320 lbs with hypertension:
- Continue GLP-1 therapy for weight loss—this will help both blood pressure and overall cardiovascular risk 3, 4
- Your HDL of 33 needs improvement through weight loss and possibly medication
- Weight reduction will reduce mechanical stress on inflamed muscles
Monitoring Your Disease
Key markers to follow:
- CK levels: Should normalize with treatment
- ESR/CRP: Should decrease
- Anti-RNP titers: May remain positive but don't always correlate with disease activity 1
- Muscle strength testing: Objective measure of treatment response
Common Pitfalls to Avoid
- Don't stop steroids abruptly—this can cause disease flare and adrenal crisis
- Don't skip the steroid-sparing agent—starting it early allows faster steroid taper and reduces long-term steroid complications
- Don't delay treatment—prolonged untreated inflammation can lead to muscle atrophy and fibrosis
- Screen for malignancy: While more common in dermatomyositis, age-appropriate cancer screening is warranted 1
Physical Therapy Is Essential
Continue physical therapy throughout treatment:
- Gentle range-of-motion exercises during active inflammation
- Progressive strengthening as inflammation improves
- Prevents contractures and maintains function 1
Your Telegram Follow-Up
The one-hour Telegram consultation after EMG results is appropriate and efficient—it allows your rheumatologist to review results, adjust treatment, and answer questions without requiring you to travel while weak. This is standard practice for stable follow-up.
Bottom line: You have a treatable autoimmune condition, not a death sentence. With appropriate immunosuppression, most patients with MCTD-associated myopathy recover substantial muscle strength and maintain good quality of life.